Evidence map›Paper›PMID 33692368›Full record

ArticleScientific reports2021

Differential expression analysis and profiling of hepatic miRNA and isomiRNA in dengue hemorrhagic fever.

Layanna Freitas de Oliveira, Amanda Araújo Serrão de Andrade, Carla Pagliari, Leda Viegas de Carvalho, Taiana S Silveira, Jedson Ferreira Cardoso, André Luiz Teles E Silva, Janaina Mota de Vasconcelos, Caroline Aquino Moreira-Nunes, Rommel Mario Rodríguez Burbano and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Cross Talk between MicroRNAs and Dengue Virus.The American journal of tropical medicine and hygiene · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Layanna Freitas de OliveiraCenter for Technological Innovation, Instituto Evandro Chagas, Ananindeua, PA, Brazil. layannafoliveira@gmail.com.
Amanda Araújo Serrão de AndradeCenter for Technological Innovation, Instituto Evandro Chagas, Ananindeua, PA, Brazil.ORCID 0000-0003-3530-7435
Carla PagliariDepartamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Leda Viegas de CarvalhoFundação Oncocentro de São Paulo, São Paulo, SP, Brazil.
Taiana S SilveiraFaculdade de Medicina de São José Do Rio Preto, São Paulo, SP, Brazil.
Jedson Ferreira CardosoCenter for Technological Innovation, Instituto Evandro Chagas, Ananindeua, PA, Brazil.ORCID 0000-0002-3680-6327
André Luiz Teles E SilvaInstituto de Ciências Biológicas, Universidade Federal do Pará, Belém, PA, Brazil.
Janaina Mota de VasconcelosCenter for Technological Innovation, Instituto Evandro Chagas, Ananindeua, PA, Brazil.
Caroline Aquino Moreira-NunesLaboratory of Pharmacogenetics, Drug Research and Development Center (NPDM), Universidade Federal Do Ceará, Fortaleza, CE, Brazil.ORCID 0000-0001-5845-3481
Rommel Mario Rodríguez BurbanoInstituto de Ciências Biológicas, Universidade Federal do Pará, Belém, PA, Brazil.
Márcio Roberto Teixeira NunesCenter for Technological Innovation, Instituto Evandro Chagas, Ananindeua, PA, Brazil.
Eduardo José Melo Dos SantosInstituto de Ciências Biológicas, Universidade Federal do Pará, Belém, PA, Brazil.
João Lídio da Silva Gonçalves Vianez JúniorCenter for Technological Innovation, Instituto Evandro Chagas, Ananindeua, PA, Brazil. vianez.iec@gmail.com.
Instituto Evandro Chagas · BRUniversidade Federal do Pará · BRFaculdade de Medicina de São José do Rio Preto · BRFundação de Amparo à Pesquisa do Estado de São Paulo · BRUniversidade de São Paulo · BRUniversidade Federal do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue virus causes dengue hemorrhagic fever (DHF) and has been associated to fatal cases worldwide. The liver is one of the most important target tissues in severe cases, due to its intense viral replication and metabolic role. microRNAs role during infection is crucial to understand the regulatory mechanisms of DENV infection and can help in diagnostic and anti-viral therapies development. We sequenced the miRNome of six fatal cases and compared to five controls, to characterize the human microRNAs expression profile in the liver tissue during DHF. Eight microRNAs were differentially expressed, including miR-126-5p, a regulatory molecule of endothelial cells, miR-122-5p, a liver specific homeostasis regulator, and miR-146a-5p, an interferon-regulator. Enrichment analysis with predicted target genes of microRNAs revealed regulatory pathways of apoptosis, involving MAPK, RAS, CDK and FAS. Immune response pathways were related to NF- kB, CC and CX families, IL and TLR. This is the first description of the human microRNA and isomicroRNA profile in liver tissues from DHF cases. The results demonstrated the association of miR-126-5p, miR-122-5p and miR-146a-5p with DHF liver pathogenesis, involving endothelial repair and vascular permeability regulation, control of homeostasis and expression of inflammatory cytokines.

Indexed as

Gene Expression ProfilingGene Expression RegulationAdultAgedDengue VirusFemaleHumansLiverMaleMicroRNAsMiddle AgedSevere DengueMicroRNAs

Identifiers

PMID33692368
PMCPMC7946910
OpenAlexW3134687595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.